Global /Canada /Financial Services /Financial Conglomerates /WOLF
chevron_leftBack
Grey Wolf Animal Health Corp. logo

Grey Wolf Animal Health Corp.

WOLF
TSXV: WOLF Delayed
1.65CAD 0%
1.19 USD
As of 5 June 2026, Grey Wolf Animal Health Corp. has a market cap of $40.59M USD, ranking #32075 globally and #1025 in Canada. It ranks #3430 in the Financial Services sector, and #537 in the Financial Conglomerates industry.
Global Rank
32075
Country Rank
1025
Sector Rank
3430
Industry Rank
537
Key Stats
Market Cap
$40.59MUSD
56.42M CAD
Enterprise Value
$53.4MUSD
74.23M CAD
Revenue (TTM)
$25.73MUSD
35.76M CAD
EBITDA (TTM)
$4.85MUSD
6.73M CAD
Net Income (TTM)
$1.19MUSD
1.66M CAD
EBITDA Margin
19%
Profit Margin
4.6%
PE Ratio
34.1
PS Ratio
1.6
PB Ratio
1.8
EV/EBITDA
10.7
Company Profile
Country (HQ)
Sector
Financial Services
Industry
Financial Conglomerates
CEO
Angela Cechetto open_in_new
Employees
40
Website
greywolfah.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% 11% 14% 27% 31% 83%

News

Loading...

Markets

Exchange Ticker Price
TSX Venture Exchange
MIC: XTSX
PRIMARY
WOLF
Grey Wolf Animal Health Corp
ISIN: CA3978851044
Shares Out.:
34.192M1 Shares Float: 26.042M2
TV:
SA:
YF:
GF:
BA:
MS:
1.65 CAD
Cboe Canada
MIC: NEOE
WOLF
Grey Wolf Animal Health Corp
ISIN: CA3978851044
TV:
SA:
YF:
GF:
BA:
MS:
1.65 CAD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Grey Wolf Animal Health Corp.

Grey Wolf Animal Health Corp. operates as an animal health and wellness company in Canada. The company operates in two segments, Animal Health Business Unit and Pharmacy Business Unit. It engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics, as well as offers pharmaceuticals for the human and animal health markets. The company provides dexmedetomidine hydrochloride oromucosal gel under the SILEO name; sedative analgesic and reversing agents for companion animals under the SEDAJECT and ATAJECT names; prescription drugs under the THYRO-TABS CANINE name; and wound care products, including medical tubes, viscose net dressings, alginate dressing, absorbent foam dressing, superabsorbent dressing, cohesive bandages, and silicone perforated tapes, as well as medical pet shirt protective wear products, such as pet shirt, pets boot, head cover, and leg sleeves. It also offers disposables comprising syringes, needles, and IV catheters; and nutraceuticals, as well as equine health products. The company is headquartered in Toronto, Canada.

Similar Companies

Industry: Financial Conglomerates (Canada)
Name
Market Cap diff.
PE
$781.87M
2K%
708.4
$644.78M
896.19M CAD
1K%
6.0
$610.44M
848.46M CAD
1K%
-
VOXR
$361.38M
502.29M CAD
790%
53.2
$321.61M
692%
-
$321.34M
692%
40.6
Industry: Financial Conglomerates (Global)
Name
Market Cap diff.
PE
INVE-A
$120.93B
1.14T SEK
298K%
5.9
402340
$71.21B
109.46T KRW
175K%
12.5
ITSA3
$31.02B
157.1B BRL
76K%
9.5
$22.11B
207.94B SEK
54K%
5.2
$19.0B
598.03B TWD
47K%
12.6
HAL
$17.86B
15.4B EUR
44K%
9.6
chevron_leftBack